1 |
Molecular profiling for acromegaly treatment: a validation study.
61
|
Puig-Domingo M...Marazuela M
|
32302973 |
2020 |
2 |
Current Status of Diagnosis and Management for Functioning Pituitary Tumors: Part I.
61
|
Thakkar K...Shah NS
|
32611887 |
2020 |
3 |
Pituicytoma Associated with Acromegaly and Cushing Disease.
61
|
Marco Del Pont F...Cervio A
|
31874293 |
2020 |
4 |
Somatostatin receptors in normal and acromegalic somatotroph cells: the U-turn of the clinician to immunohistochemistry report - a review.
61
|
Ionovici N...Popescu M
|
33544787 |
2020 |
5 |
Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of silent corticotroph adenomas.
61
|
Kasuki L...Gadelha MR
|
31773787 |
2020 |
6 |
Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors.
61
|
Re A...Cannavo S
|
33281746 |
2020 |
7 |
Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.
61
|
Dutta P...Korbonits M
|
31125088 |
2019 |
8 |
Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas.
61
|
Hage M...Kamenicky P
|
30376114 |
2019 |
9 |
Association between KISS1 rs5780218 promoter polymorphism and onset of growth hormone secreting pituitary adenoma.
61
|
Amorim PVGH...Trarbach EB
|
30318257 |
2019 |
10 |
[Evaluation of transsphenoidal adenomectomy outcomes in acromegaly using different remission criteria].
61
|
Tsiberkin AI...Grineva EN
|
30900693 |
2019 |
11 |
Malignant paraganglioma and somatotropinoma in a patient with germline SDHB mutation-genetic and clinical features.
61
|
Saavedra A...Carvalho D
|
30155846 |
2019 |
12 |
Screening of AIP Gene Variations in a Cohort of Turkish Patients with Young-Onset Sporadic Hormone-Secreting Pituitary Adenomas.
61
|
Tuncer FN...Yarman S
|
30461320 |
2018 |
13 |
Reduced protein expression of the phosphodiesterases PDE4A4 and PDE4A8 in AIP mutation positive somatotroph adenomas.
61
|
Bizzi MF...Korbonits M
|
29729370 |
2018 |
14 |
Screening for germline KCNQ1 and KCNE2 mutations in a set of somatotropinoma patients.
61
|
Iivonen AP...Raivio T
|
29703730 |
2018 |
15 |
Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas.
61
|
Alhambra-Exposito MR...Luque RM
|
29670116 |
2018 |
16 |
Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland.
61
|
Hernandez-Ramirez LC...Korbonits M
|
29507682 |
2018 |
17 |
Imatinib Inhibits GH Secretion From Somatotropinomas.
61
|
Gupta P...Dutta P
|
30210447 |
2018 |
18 |
The genetic background of acromegaly.
61
|
Gadelha MR...Korbonits M
|
28161730 |
2017 |
19 |
Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues.
61
|
Liu W...Zhang Z
|
28396686 |
2017 |
20 |
Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma.
61
|
Matsumoto R...Takahashi Y
|
27498687 |
2016 |
21 |
Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening.
61
|
Mangupli R...Beckers A
|
27287035 |
2016 |
22 |
Polymorphisms in MEN1 and DRD2 genes are associated with the occurrence and characteristics of pituitary adenomas.
61
|
Peculis R...Klovins J
|
27185868 |
2016 |
23 |
A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
61
|
Cansu GB...Stratakis CA
|
27838609 |
2016 |
24 |
Long-term first line medical treatment in a 4-year-old girl with Xq26.3 microduplication-negative somatotropinoma. Case report and literature review.
61
|
Maggioli C...Cappa M
|
26812771 |
2016 |
25 |
The Role of gsp Mutations on the Development of Adrenocortical Tumors and Adrenal Hyperplasia.
61
|
Villares Fragoso MC...Mariani BM
|
27512387 |
2016 |
26 |
[Mental disorders in patients with acromegaly].
61
|
Bobrov AE...Alexandrova MM
|
27735894 |
2016 |
27 |
Hemostatic Disorders in Hormonally Active Pituitary Tumors.
61
|
Swiatkowska-Stodulska R...Sworczak K
|
26285071 |
2015 |
28 |
Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas.
61
|
Luque RM...Castano JP
|
25637790 |
2015 |
29 |
Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.
61
|
Niyazoglu M...Kadioglu P
|
23743763 |
2014 |
30 |
Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.
61
|
Demir H...Karhu A
|
25291362 |
2014 |
31 |
A clinically novel AIP mutation in a patient with a very large, apparently sporadic somatotrope adenoma.
61
|
Salvatori R...Beckers A
|
25136448 |
2014 |
32 |
Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
61
|
Cai F...Wang RZ
|
24050928 |
2013 |
33 |
Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
61
|
Garcia EA...Korbonits M
|
24152687 |
2013 |
34 |
Complex rhythmicity and age dependence of growth hormone secretion are preserved in patients with acromegaly: further evidence for a present hypothalamic control of pituitary somatotropinomas.
61
|
Ribeiro-Oliveira A...Barkan AL
|
23640965 |
2013 |
35 |
Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
61
|
Beckers A...Karhu A
|
23371967 |
2013 |
36 |
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
61
|
Cuny T...Barlier A
|
23321498 |
2013 |
37 |
Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor.
61
|
Guaraldi F...Salvatori R
|
22527616 |
2012 |
38 |
AIP Familial Isolated Pituitary Adenomas
61
|
Korbonits M...Kumar AV
|
22720333 |
2012 |
39 |
Validation of immunohistochemistry for somatostatin receptor subtype 2A in human somatotropinomas: comparison between quantitative real time RT-PCR and immunohistochemistry.
61
|
Wildemberg LE...Gadelha MR
|
21897115 |
2012 |
40 |
Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?
61
|
Xekouki P...Stratakis CA
|
22170724 |
2012 |
41 |
'Silent' somatotropinoma.
61
|
Pawlikowski M...Winczyk K
|
22538745 |
2012 |
42 |
Growth of an aggressive tumor during pregnancy in an acromegalic patient.
61
|
Kasuki L...Gadelha MR
|
22240890 |
2012 |
43 |
Clinical features and therapeutic outcomes of patients with acromegaly: single-center experience.
61
|
Dusek T...Korsic M
|
21750393 |
2011 |
44 |
Sporadic and genetic forms of paediatric somatotropinoma: a retrospective analysis of seven cases and a review of the literature.
61
|
Nozieres C...Nicolino M
|
22024364 |
2011 |
45 |
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.
61
|
Tichomirowa MA...Beckers A
|
21753072 |
2011 |
46 |
Acrogigantism and facial asymmetry: McCune-Albright syndrome.
61
|
Subbiah S...Bhansali A
|
22145488 |
2011 |
47 |
Familial acromegaly - case study of two sisters with acromegaly.
61
|
Malicka J...Nowakowski A
|
22144223 |
2011 |
48 |
Clinical features and treatment of pediatric somatotropinoma: case study of an aggressive tumor due to a new AIP mutation and extensive literature review.
61
|
Personnier C...Polak M
|
21546764 |
2011 |
49 |
Thyrotropin secreting pituitary adenoma accompanying a silent somatotropinoma.
61
|
Berker D...Guler S
|
21845579 |
2011 |
50 |
Familial isolated pituitary adenomas experience at a single center: clinical importance of AIP mutation screening.
61
|
Pinho LK...Gadelha MR
|
21340155 |
2010 |